Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia

This study has been completed.

Study NCT00217412 Information provided by National Cancer Institute (NCI)

First Received: September 20, 2005 Last Updated: October 17, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	September 2009 (Final data collection date for primary outcome measure)